Filing Flows › Viemed Healthcare (VMD) › Q2 2026 › vs Q1 2026
Viemed Healthcare (VMD) Q2 2026 vs Q1 2026 (quarter over quarter)
Viemed Healthcare's revenue rose $2.7M (+4%) from $75.4M in Q1 2026 to $78.1M in Q2 2026. Gross margin 57.7% against 56.8% (+0.9 pts).
Viemed Healthcare, Q2 2026: revenue $78.1M (+24% year over year), operating margin 5.7%, net earnings $2.8M, operating cash flow $15.9M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Gross margin | 57.7% | 56.8% | +0.9 pts |
| Operating margin | 5.7% | 5.7% | +0.0 pts |
| Net margin | 3.5% | 3.4% | +0.1 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $78.1M | $75.4M | $2.7M | +4% |
| Gross profit | $45.0M | $42.8M | $2.2M | +5% |
| Cost of revenue | $33.0M | $32.6M | $462K | +1% |
| Operating profit | $4.5M | $4.3M | $165K | +4% |
| Operating expenses | $40.6M | $38.5M | $2.1M | +5% |
| Pre-tax earnings | $4.1M | $4.0M | $60K | +2% |
| Other expense, net | $410K | $305K | $105K | +34% |
| Research & development | $504K | $579K | −$75K | -13% |
| SG&A | $37.1M | $34.8M | $2.3M | +7% |
| Other operating costs | $3.0M | $3.2M | −$209K | -7% |
| Net earnings | $2.8M | $2.6M | $182K | +7% |
| Minority interests | $136K | $131K | $5K | +4% |
| Income tax | $1.2M | $1.3M | −$127K | -10% |
| Depreciation & amortization | $7.5M | $7.6M | −$101K | -1% |
| Share-based compensation | $2.0M | $2.5M | −$419K | -17% |
| Working capital & other | $3.6M | −$4.6M | $8.2M | — |
| Operating cash flow | $15.9M | $8.1M | $7.8M | +97% |
Questions
How much did Viemed Healthcare's revenue grow quarter over quarter in Q2 2026?
Viemed Healthcare's revenue rose $2.7M (+4%) from $75.4M in Q1 2026 to $78.1M in Q2 2026. Gross margin 57.7% against 56.8% (+0.9 pts).